News

Deal Announcements

KineMed Lands New Venture Capital Equity

Monday, July 27, 2015 5:46:00 AM PDT | VentureDeal
   Emeryville, California  --  Pharmaceutical company KineMed has secured $450,000 in new equity investment, according to an SEC filing.

KineMed works with major pharmaceutical and biotech companies to "produce data on target engagement, toxicity and disease progression to accelerate drug development and reduce the overall costs and risks."

Investors in the financing were not disclosed, nor was how the company intends to use the proceeds.

KineMed is still seeking $10.35 million in additional financing in the current round.

The company was founded in 2001 by president, CEO and chairman David Fineman.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1